893762-27-1

Basic information

• Product Name: Methyl 2-(3-Methyl-1H-1,2,4-triazol-5-yl)acetate
• Synonyms: Methyl 2-(3-Methyl-1H-1,2,4-triazol-5-yl)acetate;methyl 2-(5-methyl-2H-1,2,4-triazol-3-yl)acetate
• CAS NO: 893762-27-1
• Molecular Formula: C₆H₉N₃O₂
• Molecular Weight: 155.15456
• Mol File: 893762-27-1.mol

Chemical Properties

• Boiling Point: 333.5±25.0 °C(Predicted)
• Appearance: /
• Density: 1.258±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 9.82±0.40(Predicted)
• CAS DataBase Reference: Methyl 2-(3-Methyl-1H-1,2,4-triazol-5-yl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-(3-Methyl-1H-1,2,4-triazol-5-yl)acetate(893762-27-1)
• EPA Substance Registry System: Methyl 2-(3-Methyl-1H-1,2,4-triazol-5-yl)acetate(893762-27-1)

Safety Data

• Hazardous Substances Data: 893762-27-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 2-(3-Methyl-1H-1,2,4-triazol-5-yl)acetate is used as an intermediate in the synthesis of various pharmaceutical products. Its unique structure allows it to be a key component in the development of new drugs and compounds, contributing to the advancement of medical treatments.
Used in Research and Development:
In the realm of research and development, Methyl 2-(3-Methyl-1H-1,2,4-triazol-5-yl)acetate serves as a valuable precursor for the production of innovative drugs and compounds. Its versatility makes it an essential tool for scientists and researchers working on novel formulations and applications in the field of chemistry and medicine.

Upstream product

• 67-56-1 methanol 
• 720706-28-5 2-(5-METHYL-1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID 

Downstream Products

• 1124150-47-5 C₁₅H₁₇N₃O₄ 

Relevant articles and documents

Combinatorial synthesis of 3,5-Dimethylene substituted 1,2,4-Triazoles

Combinatorial cyclizations of imidates and hydrazides with methylene linked R groups, generated from the corresponding nitriles and carboxylic acids, respectively, provided a large library of 3,5-dimethylene substituted 1,2,4- trizoles. 2011 Bentham Science Publishers Ltd.

THIAZOLE DERIVATIVES AS CXCR3 RECEPTOR MODULATORS

The invention encompasses compounds of Formula I (I) or pharmaceutically acceptable salts thereof, which are antagonist of the CXCR3 chemokine receptor useful for the treatment or prevention of pathogenic inflammatory processes, autoimmune diseases or graft rejection processes. Methods of use and pharmaceutical compositions are also encompassed.